Knauer Announces ModuVision Acquisition
Knauer Wissenschaftliche Geräte (Berlin, Germany) has announced the acquisition of ModuVision BV, an automation focused company based in Vlissingen, the Netherlands.
“We look forward to cooperating very closely with the experts from ModuVision. This acquisition fits very well to our strategy,” said Alexandra Knauer and Carsten Losch, CEO’s of Knauer.
ModuVision BV will continue to exist as an affiliate of Knauer. All contracts with employees, suppliers, and partners will remain valid. ModuVision will continue to serve customers in the field of GC and LC.
“We welcome the partnership with Knauer very much and we expect a great benefit for both companies,” said Jan Willem Mol, ModuVision CEO.
For more information, please visit:
www.knauer.net
Pittcon 2025: Xiao Su Discusses His Work in Electrochemical Separations
March 13th 2025In this video interview with Xiao Su, he dives deeper into the research that he and his team are conducting with redox-active polymers and the applicability of electrochemical approaches in separation science.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Pittcon 2025: Kate Perrault Uptmor Talks About Multidimensional GC and Mentorship
March 13th 2025In our interview with Kate Perrault Uptmor, we asked her about the resources available for those interested in learning more about multidimensional chromatography, and current trends happening in separation science that are of particular note.
Analyzing Effects of Adverse Cardiovascular Events on Chronic Kidney Disease with HPLC
March 13th 2025Researchers investigated the potential association between plasma apolipoprotein M (APOM) levels and the risk of adverse cardiovascular outcomes in individuals with chronic kidney disease (CKD). Plasma sphingosine-1-phosphate (S1P) levels were measured by high performance liquid chromatography (HPLC).
